2Nissen P, Hansen J, et al. The structural basis of ribo- some ctivity in peptide bond synthesis[J]. Science, 2000 (289) : 920-930.
3Moore P B,Steitz T A . The involvement of NA in ribo- some function[J]. Nature, 2002(18) :229-235.
4Yam W K, Wahab H A. Molecular insights into 14- membered macrolides using the MM-PBSA method[J]. Journal of Chemical Information and Modelling, 2009 (49) :1558-1567.
5Mikasa K, Kita E, et al. The anti-inflammatory effect of erythromycin in zymosaninduced peritonitis oI mice [J]. Journal of Antimicrobial Chemotherapy, 1992(30): 339-348.
6Takeshita K, Yamagishi I, et al. Immunological and an- ti-inflammatory effects of clarithromycin:Inhibition of in- terleukin 1 production of murine peritoneal macrophages [J]. Drugs under Experimental and Clinical Research, 1989(15) :527-533.
7Leiva M, Ruiz-Bravo A, et al. Telithromycin inhibits the production of proinflammatory mediators and the ac- tivation of NFkappaB in in vitro-stimulated murine cells [J]. FEMS Immunology and Medical Microbiology, 2008(53) :343-350.
8Villarino N, Lesman S, et al. Pulmonary pharmacoki-netics of tulathromycin in swine. Part 2: Intra-airway compartments[J]. Journal of Veterinary Pharmacology and Therapeutics, 2013(36) :340-349.
9Clothier K A, Jordan D M, et al. Safety evaluation of tulathromycin use in the caprine species: Tutathromycin toxicity assessment in goats [J]. Journal of Veterinary Pharmacology and Therapeutics, 2010(33) : 499- 502.
10Villarinoa N, Brown S A,et al. The role of the macroli- de tulathromyein in veterinary medicine[J]. The Veteri- nary Journal,2013(198) :352-357.
